Expressive Wealth LLC Buys New Stake in CME Group Inc. $CME

Expressive Wealth LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) during the 2nd quarter, Holdings Channel reports. The firm bought 2,522 shares of the financial services provider’s stock, valued at approximately $557,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. Whipplewood Advisors LLC grew its stake in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new stake in shares of CME Group during the fourth quarter valued at about $27,000. Hilton Head Capital Partners LLC acquired a new stake in CME Group in the fourth quarter worth about $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in CME Group in the second quarter worth about $28,000. Finally, Legacy Wealth Managment LLC ID grew its position in CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after buying an additional 71 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of several research analyst reports. Wall Street Zen cut shares of CME Group from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 1st. The Goldman Sachs Group reduced their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. UBS Group decreased their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a report on Monday, July 6th. TD Cowen lowered their price objective on shares of CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Finally, Raymond James Financial reissued an “outperform” rating and set a $320.00 target price on shares of CME Group in a report on Thursday, July 2nd. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $288.56.

Get Our Latest Analysis on CME Group

Insider Activity at CME Group

In other CME Group news, Director William R. Shepard bought 325 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 0.30% of the stock is owned by insiders.

CME Group Trading Up 1.5%

Shares of CME stock opened at $274.98 on Friday. The stock has a 50-day simple moving average of $251.17 and a 200 day simple moving average of $279.65. The stock has a market capitalization of $98.88 billion, a P/E ratio of 23.32, a P/E/G ratio of 3.16 and a beta of 0.23. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the business earned $2.96 earnings per share. CME Group’s revenue for the quarter was up .8% compared to the same quarter last year. On average, sell-side analysts expect that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is currently 44.11%.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.